Life Expectancy News and Research

RSS

Life expectancy is the expected (in the statistical sense) number of years of life remaining at a given age. It is denoted by e''x'', which means the average number of subsequent years of life for someone now aged ''x'', according to a particular mortality experience.

GCP could help lengthen life expectancy of certain prostate cancer patients

A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found.

21 Feb 2013

Air pollution exposure raises cardiac death rate

Long-term exposure to high levels of particulate matter with a diameter of 2.5 mm or below increases a person’s chance for dying following a heart attack, show results from a large UK study.

20 Feb 2013

Air pollution associated with increased deaths after heart attacks

Air pollution contributes to an increased number of deaths among patients who have been admitted to hospital with heart attacks, according to a study published online in the European Heart Journal

20 Feb 2013

Tranylcypromine may also hold promise in treating sickle cell disease

An antidepressant drug used since the 1960s may also hold promise for treating sickle cell disease, according to a surprising new finding made in mice and human red blood cells by a team from the University of Michigan Medical School.

19 Feb 2013

U.K., Ugandan Government sign new healthcare alliance

A Ugandan-UK Healthcare Alliance, which will help improve health care for people living in the East African country, has been launched this week after being developed by a University of Manchester health professional.

From The University of Manchester 19 Feb 2013

More people meeting recommended goals in three key markers of diabetes control

More people are meeting recommended goals in the three key markers of diabetes control, according to a study conducted and funded by the National Institutes of Health and the Centers for Disease Control and Prevention.

16 Feb 2013

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.

14 Feb 2013

Glimmer of hope for imatinib-resistant GIST

The monoclonal antibody SR1 can significantly inhibit gastrointestinal stromal tumor cell growth, report researchers in the Proceedings of the National Academy of Sciences.

7 Feb 2013

Baby boomers not as healthy as previously believed

Despite having a reputation of being the healthiest and most active generation, baby boomers are actually in worse overall health than their parents, according to a new study by researchers at the West Virginia University School of Medicine.

6 Feb 2013

No difference in rates of late-stage breast cancer between women screened annually and biennially

Among older women, getting a mammogram every two years was just as beneficial as getting a mammogram annually, and led to significantly fewer false positive results, according to a study led by UC San Francisco.

6 Feb 2013

UCSD receives $3.4M NIMH grant to study successful aging in HIV-infected adults

The National Institute of Mental Health has awarded a $3.4 million grant to a team of researchers at the University of California, San Diego School of Medicine to study successful aging in HIV-infected adults. HIV is a serious, chronic, medical disease that affects the lives of more than one million Americans.

5 Feb 2013

Study finds serious long-term side effects following prostate cancer treatments

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

31 Jan 2013

Clinical trial to evaluate cyclodextrin against Niemann-Pick disease type C1

A clinical trial to evaluate a drug candidate called cyclodextrin as a possible treatment for Niemann-Pick disease type C1 (NPC), a rare and fatal genetic disease, will start today, researchers announced.

24 Jan 2013

SOPHIE project to evaluate social and economic policies’ impact on health inequalities

Europe will assess the impact of social and economic policies on health inequalities through the SOPHIE project. Health inequalities are avoidable and unfair differences determined by the circumstances in which people of different social groups are born, live, work and age.

23 Jan 2013

Chronic heart failure treatment, Inspra (eplerenone), accepted for use within NHS Wales

Inspra (eplerenone) has now been accepted by the All Wales Medicines Strategy Group (AWMSG) for use in adult patients with chronic heart failure (CHF) NYHA class II, in combination with standard optimal therapy...

22 Jan 2013

Schizophrenics more likely to die from cardiovascular disease and cancer

A new study from Lund University in Sweden shows that the average life expectancy of men and women with schizophrenia is 15 years and 12 years shorter respectively than for those who do not suffer from the disease.

22 Jan 2013

Current smokers with HIV more likely to get bacterial pneumonia

Bacterial pneumonia is one of the commonest and most serious infections occurring in people infected with HIV. A metanalysis of cohort and case control studies published in BioMed Central's open access journal BMC Medicine finds that current smokers with HIV were at double the risk of bacterial pneumonia than non-smoking counterparts, but that when people stopped smoking their risk was reduced.

21 Jan 2013

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.

18 Jan 2013

New compounds can target RNase H enzyme in HIV

Scientists who study HIV are facing a troubling consequence of their own success. They created drugs that can now give infected patients almost normal life expectancy. However, those same drugs will eventually cause the constantly mutating virus to evolve into a form that eludes current treatments.

18 Jan 2013

Viewpoints: N.Y. gun law could pose problems for health professionals; 'Jarring discrepancy' between medical costs and premium increases; State officials wage battle against health law

The broad gun control bill approved Tuesday by the New York Legislature substantially strengthens the state's gun control laws. ... Some sections of the law, however, were not fully vetted in the rush. One provision asks health care professionals -; physicians, psychologists, registered nurses or licensed clinical social workers -; to report to local health care officials when they have reason to believe that patients could harm themselves or others. ... The provision would seem to raise significant legal questions.

16 Jan 2013